HD Yes thanks So if we all agree that end of 2nd qt 2016 is a MUST SHOW BENEFIT by date for Reduce It ...how much of the qtly payment will Pharmakon allow to be deferred ...to "maintain business operations "
See my response to JL
If RI fails to show benefit by end of 2nd Qt 2016 ( as most seem to agree ) then the patents may be of little value and Pharmakon is unlikely to get much of anything from anyone past that date
Since you were kind enough to calculate sales projections ...can you play the Banker and run a few scenarios on how Pharmakon gets back the $100m they invested before then ...or do you figure they'll roll the dice , and gamble on a positive readout and wait to 2nd Qt 2017 for their money. Thanks Kiwi